Additionally, as previous clinical trials have shown that the SMA disease trajectory varies both by treatment and SMN2 copy number [3, 12, 14, 15], it is important for family members to be aware of the SMN2 copy number of their loved one to manage the family’s expectations of the SMA disease course. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.